Gennex Laboratories Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 05-07-2024
- Paid Up Capital ₹ 28.46 Cr
as on 05-07-2024
- Company Age 34 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 42.37 Cr
as on 05-07-2024
- Satisfied Charges ₹ 26.13 Cr
as on 05-07-2024
- Revenue 9.44%
(FY 2023)
- Profit 16.20%
(FY 2023)
- Ebitda -14.78%
(FY 2023)
- Net Worth 79.60%
(FY 2023)
- Total Assets 41.07%
(FY 2023)
About Gennex Laboratories
The Corporate was formerly known as Pharmasia Drugs And Chemicals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 28.46 Cr.
The company currently has active open charges totaling ₹42.37 Cr. The company has closed loans amounting to ₹26.13 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Gennex Laboratories Limited India are Dinesh Kejriwal as COMPANY SECRETARY and Laxmipat Baid as Cfo. Ranga Avasarala, China Sangeetrao, Amudala Rao, and Three other members serve as directors at the Company.
- CIN/LLPIN
L24230TG1990PLC011168
- Company No.
011168
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 Mar 1990
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Gennex Laboratories Limited offer?
Gennex Laboratories Limited offers a wide range of products and services, including Business Planning and Management, Business Consultant, Pharma Ingredients & Raw Materials, Anti Infective API, Marketing Services & Consultants, Marketing Services.
Who are the key members and board of directors at Gennex Laboratories?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arihant Baid  | Managing Director | 18-May-2012 | Current |
| Dinesh Kejriwal | Company Secretary | 20-Apr-2023 | Current |
| Laxmipat Baid | CFO | 14-Feb-2015 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ranga Avasarala | Director | 21-Dec-2020 | Current |
| China Sangeetrao | Additional Director | 12-Mar-2024 | Current |
| Amudala Rao | Director | 21-Dec-2020 | Current |
| Sadhana Bhansali | Director | 30-Sep-2014 | Current |
| Y Ravinder | Director | 22-Mar-2003 | Current |
Financial Performance and Corporate Structure Insights of Gennex Laboratories.
Gennex Laboratories Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.44% increase. The company also saw a substantial improvement in profitability, with a 16.2% increase in profit. The company's net worth Soared by an impressive increase of 79.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gennex Laboratories?
In 2022, Gennex Laboratories had a promoter holding of 22.05% and a public holding of 77.95%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Prudential Sugar Corporation LimitedActive 34 years 17 daysSadhana Bhansali and Y Ravinder are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 02 Mar 2023 | ₹0.40 M | Open |
Others Creation Date: 27 Feb 2023 | ₹20.00 Cr | Open |
Others Creation Date: 07 Feb 2023 | ₹1.38 Cr | Open |
How Many Employees Work at Gennex Laboratories?
Gennex Laboratories has a workforce of 103 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gennex Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gennex Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
